D en D PHARMA SA
D en D PHARMA reported total assets of €1.55m at the end of the 2025 financial year (annual accounts filed with the NBB on 31 Aug 2026).
The score of D en D PHARMA shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +36 % Total assets +46 %
Accounts of the company itself (not consolidated).
The full file covers 9 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
D en D PHARMA's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 31 Aug 2026
- Year ended 31 Dec 2024filed on 29 Aug 2025
- Year ended 31 Dec 2023filed on 20 Aug 2024
- Year ended 31 Dec 2022filed on 07 Aug 2023
- Year ended 31 Dec 2021filed on 26 Jul 2022
D en D PHARMA's financial analysis
- Solvency87.0%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of D en D PHARMA
D en D PHARMA's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0457.694.005
- VAT number
- BE0457694005
- Peppol
- Registered · 0208:0457694005 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 04 Apr 1996
- Registered office
- 2600 Antwerp
- Latest accounts
- 2025 · filed on 31 Aug 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
D en D PHARMA (SA) has been based in Antwerp since 1996, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 149,163 € and equity of €1.35m; its revenue is not published. Its solvency stands at 87.0%, above the median of its sector (44.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to D en D PHARMA
Companies in the same business, of comparable size and area, outside its group.
- Apotheek Paleis Retail sale of pharmaceutical products Antwerp · balance sheet €1.59m
- Jeandarme Manufacture of pharmaceutical preparations Sint-Truiden · balance sheet €1.60m
- Pharmacoz Retail sale of pharmaceutical products Gerpinnes · balance sheet €1.55m
- Pharmacie Angely Retail sale of pharmaceutical products Namur · balance sheet €1.83m
- Laboratoires Risselin Retail sale of pharmaceutical products Frasnes-lez-Anvaing · balance sheet €1.17m
- Grenez-Ocmant Retail sale of pharmaceutical products Le Roeulx · balance sheet 712,128 €
- Devlies Pharma Retail sale of pharmaceutical products Kortrijk · balance sheet 675,641 €
- Apotheke Hardy Pharmacie Retail sale of pharmaceutical products Amel · balance sheet €1.60m
Frequently asked questions about D en D PHARMA
What is the revenue of D en D PHARMA?
D en D PHARMA files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of D en D PHARMA?
In Belgium, the VAT number is the company number prefixed with BE: BE0457694005 for D en D PHARMA, if the company is VAT-registered. Its company number (CBE) is 0457.694.005.
Where is the registered office of D en D PHARMA?
According to the CBE register, the registered office of D en D PHARMA is in 2600 Antwerp.
What is the equity of D en D PHARMA?
At the close of the 2025 financial year, the equity of D en D PHARMA amounts to 1,346,016 €, a solvency of 87.0% of total assets.
Who manages D en D PHARMA?
The register lists 4 active mandates at D en D PHARMA. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of D en D PHARMA
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →